Irukandji syndrome: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Background''' | '''Background''' | ||
*Caused by certain jellyfish from the Cubozoa class (box jellyfish) species | *Caused by certain jellyfish from the Cubozoa class (box jellyfish) species | ||
*Usually develops within 2 hours of envenomation & can last up to 2 days <ref> Hauglid, C., Kiel, J., & Schmidt, A. (2021, April 23). Emergen-Sea Medicine: Overview of Marine Envenomations - Page 4 of 5. ACEP Now. https://www.acepnow.com/article/emergen-sea-medicine-overview-of-marine-envenomations/4/.</ref> | *Usually develops within 2 hours of envenomation & can last up to 2 days <ref> Hauglid, C., Kiel, J., & Schmidt, A. (2021, April 23). Emergen-Sea Medicine: Overview of Marine Envenomations - Page 4 of 5. ACEP Now. https://www.acepnow.com/article/emergen-sea-medicine-overview-of-marine-envenomations/4/.</ref> | ||
* The sympathomimetic-like manifestations are due to the venom, which is proteinaceous and contains a neural sodium channel activator. **Acts on the same sodium channels that are sensitive to tetrodotoxin, causing the release of catecholamines, particularly norepinephrine and epinephrine, and also direct vasoconstrictor effects.<ref>Kong EL, Nappe TM. Irukandji Syndrome. [Updated 2021 May 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562264/</ref> | |||
'''Clinical Features''' | |||
*Rare but potentially fatal complications can manifest in diverse ways: | *Rare but potentially fatal complications can manifest in diverse ways: | ||
**Myalgias | **Myalgias | ||
Revision as of 22:20, 22 July 2021
Background
- Caused by certain jellyfish from the Cubozoa class (box jellyfish) species
- Usually develops within 2 hours of envenomation & can last up to 2 days [1]
- The sympathomimetic-like manifestations are due to the venom, which is proteinaceous and contains a neural sodium channel activator. **Acts on the same sodium channels that are sensitive to tetrodotoxin, causing the release of catecholamines, particularly norepinephrine and epinephrine, and also direct vasoconstrictor effects.[2]
Clinical Features
- Rare but potentially fatal complications can manifest in diverse ways:
- Myalgias
- Back pain
- Chest pain
- Abdominal pain
- Nausea and vomiting
- Diaphoresis
- Hypertensive crisis
- Cardiogenic pulmonary edema
- Intracranial hemorrhage
- Death
Management [3]
- Manage pain with 4-5% acetic acid/vinegar & Hot water immersion (111-114F)
- IV magnesium sulfate (0.2mmol/kg, max 10mmol in adults) given as a bolus over 5-15 minutes for pain refractory to opioids
- Hypertension should be treated with short-acting titratable medications (eg., phentolamine, esmolol, nicardipine, nitroprusside) d/t potential for hypotension in the later stages of toxicity
- ↑ Hauglid, C., Kiel, J., & Schmidt, A. (2021, April 23). Emergen-Sea Medicine: Overview of Marine Envenomations - Page 4 of 5. ACEP Now. https://www.acepnow.com/article/emergen-sea-medicine-overview-of-marine-envenomations/4/.
- ↑ Kong EL, Nappe TM. Irukandji Syndrome. [Updated 2021 May 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562264/
- ↑ Hauglid, C., Kiel, J., & Schmidt, A. (2021, April 23). Emergen-Sea Medicine: Overview of Marine Envenomations - Page 4 of 5. ACEP Now. https://www.acepnow.com/article/emergen-sea-medicine-overview-of-marine-envenomations/4/.